Connor, Clark & Lunn Investment Management Ltd. Incyte Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $26 Billion
- Q2 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Incyte Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 458,256 shares of INCY stock, worth $39.1 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
458,256
Previous 533,717
14.14%
Holding current value
$39.1 Million
Previous $32.3 Million
3.43%
% of portfolio
0.12%
Previous 0.15%
Shares
32 transactions
Others Institutions Holding INCY
# of Institutions
732Shares Held
202MCall Options Held
516KPut Options Held
265K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.62 Billion21.22% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.82 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.1MShares$1.72 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.6MShares$1.25 Billion0.6% of portfolio
-
State Street Corp Boston, MA9.88MShares$843 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $19B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...